News | April 02, 2026
Lupin completes acquisition of VISUfarma
The move represents a significant milestone in Lupin’s strategy to expand its specialty care portfolio and strengthen its presence in Europe
The move represents a significant milestone in Lupin’s strategy to expand its specialty care portfolio and strengthen its presence in Europe
The approval covers pediatric patients without a matched sibling donor for stem cell transplant
The therapy works by targeting interleukin-13, a key driver of inflammation behind eczema symptoms such as itching, skin damage, and infection
High-level results from the Phase III OBERON and TITANIA trials revealed that the first-in-class monoclonal antibody reduced the annual rate of moderate-to-severe COPD exacerbations compared with placebo
The programme aims to provide critical healthcare services to approximately 4 lakh people in remote and resource-scarce communities
The Trust’s shift from single-use compostable cups to a reusable system was driven by the need to reduce environmental impact and control long-term costs
TERN-701, a next-generation therapy targeting chronic myeloid leukemia (CML), a form of blood cancer that still presents treatment challenges despite decades of advances
They stressed that while the drug is clinically proven to support weight and blood sugar control, it must be prescribed only after careful patient evaluation and used under strict medical supervision.
New targeted pill offers hope for adults and teens with moderate-to-severe plaque psoriasis
Call it a major breakthrough for diagnostic imaging
Subscribe To Our Newsletter & Stay Updated
